Management of post-traumatic stress disorder in veterans and military service members: A review of pharmacologic and psychotherapeutic interventions since 2016

This article updates the reader about advances in research in PTSD treatment from 2016-2021 for veterans and military service members as well as the evolving recommendations of clinical practice guidelines.

Article Abstract:

“Purpose of Review: It is vitally important that providers treating post-traumatic stress disorder continue to stay abreast of research advances in the treatment of this disorder. This article updates the reader about advances in research in PTSD treatment in the past four years as well as the evolving recommendations of clinical practice guidelines.

Recent Findings: One of the most important developments is that trauma-focused therapy (TFT) has emerged as the first-line treatment for PTSD with pharmacologic options often being noted as second-line or adjunctive.

Summary: The quality and quantity of research into the treatment of PTSD continue to grow; however, the pace of research into treatment options lags behind our understanding of the development, course, and prognosis of the disorder. The development of new research-based evidence in the treatment of PTSD, both pharmacologic and psychotherapeutic, is needed and likely to necessitate frequent updates and re-evaluations of clinical practice guidelines.”

Article Access

Purchase/Subscription Required